MEIRAGTX HLDGSDL-0000388
MeiraGTx Holdings plc, a clinical stage genetics medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia. It is also developing AAV-AQP1 in Phase 2 trial for radiation-induced grade 2/3 … Read more
Market Cap & Net Worth: MEIRAGTX HLDGSDL-0000388 (328)
MEIRAGTX HLDGSDL-0000388 (F:328) has a market capitalization of $528.78 Million (€515.14 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #14408 globally and #1495 in its home market, demonstrating a 8.47% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MEIRAGTX HLDGSDL-0000388's stock price €6.40 by its total outstanding shares 80490889 (80.49 Million).
MEIRAGTX HLDGSDL-0000388 Market Cap History: 2019 to 2026
MEIRAGTX HLDGSDL-0000388's market capitalization history from 2019 to 2026. Data shows change from $1.50 Billion to $528.78 Million (-13.01% CAGR).
MEIRAGTX HLDGSDL-0000388 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MEIRAGTX HLDGSDL-0000388's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 328 by Market Capitalization
Companies near MEIRAGTX HLDGSDL-0000388 in the global market cap rankings as of March 19, 2026.
Key companies related to MEIRAGTX HLDGSDL-0000388 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
MEIRAGTX HLDGSDL-0000388 Historical Marketcap From 2019 to 2026
Between 2019 and today, MEIRAGTX HLDGSDL-0000388's market cap moved from $1.50 Billion to $ 528.78 Million, with a yearly change of -13.01%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €528.78 Million | -2.29% |
| 2025 | €541.17 Million | +11.97% |
| 2024 | €483.34 Million | -7.87% |
| 2023 | €524.65 Million | +8.55% |
| 2022 | €483.34 Million | -71.60% |
| 2021 | €1.70 Billion | +64.80% |
| 2020 | €1.03 Billion | -30.94% |
| 2019 | €1.50 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of MEIRAGTX HLDGSDL-0000388 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $528.78 Million USD |
| MoneyControl | $528.78 Million USD |
| MarketWatch | $528.78 Million USD |
| marketcap.company | $528.78 Million USD |
| Reuters | $528.78 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.